statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Krissy Wright...

Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiol Therapeutics (CRDL Research Report), Paragon 28...

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Paragon 28 (FNA Research Report) and Caribou Biosciences...

Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Paragon 28 reaffirms FY24 revenue $249M-$259M, consensus $253.92M

Paragon 28 reports preliminary Q1 revenue $60.8M-$61.1M, consensus $58.74M

Latest Ratings for FNA
 DateFirmActionFromTo Mar 2022B of A SecuritiesMaintainsBuy Mar 2022Canaccord GenuityMaintainsBuy Feb 2022NeedhamMaintainsBuy
 View More Analyst Ratings for FNA...

Unveiling 4 Analyst Insights On Paragon 28

Paragon 28 falls -11.8%

OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx, a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking...

Appointment of Stephen M. Deitsch as new Chief Financial Officer

Needham  Company LLC reissued their buy rating on shares of Paragon 28 (NYSE:FNA - Free Report) in a research note published on Thursday, Benzinga reports. Needham  Company LLC currently...

Needham & Company LLC Reaffirms Buy Rating for Paragon 28 (NYSE:FNA)

Paragon 28 (NYSE:FNA  Get Free Report)s stock had its overweight rating reissued by analysts at Piper Sandler in a report issued on Wednesday, Benzinga reports. They...

Paragon 28 (NYSE:FNA) Given "Overweight" Rating at Piper Sandler

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.

Volume	552,698.00
52-Wk High	$19.00
52-Wk Low	$7.95

FNA Paragon 28 Inc

About

Feed

News

Sentiment

Earnings

Fundamentals